- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Immediate Type Hypersensitivity in Canada
Total 5041 results
-
University of CalgaryCanadian Institutes of Health Research (CIHR); University of AlbertaTerminatedInfant, Premature, Diseases | Asthma | Asthma in Children | Infant | Infant, Extremely Premature | AllergiesCanada
-
GlaxoSmithKlineQuintiles IMSCompleted
-
Janssen Research & Development, LLCCompletedAsthmaUnited States, France, United Kingdom, Germany, Israel, Canada
-
GlaxoSmithKlineCompletedAsthmaPoland, Romania, Russian Federation, United States, Canada
-
AbbVieBoehringer IngelheimCompletedAsthmaUnited States, Korea, Republic of, Belgium, Taiwan, Canada, Germany, United Kingdom, France, Netherlands, Poland
-
Boston Scientific CorporationCompletedAsthmaUnited States, United Kingdom, Australia, Brazil, Canada, Denmark, Netherlands
-
AstraZenecaCompleted
-
Circassia LimitedAdiga Life Sciences, Inc.Completed
-
SkyePharma AGCompleted
-
GlaxoSmithKlineIqvia Pty LtdRecruitingAsthmaUnited States, Australia, Canada, France, Germany, Italy, Japan, Poland, Spain, China, Czechia, Hungary, Taiwan, United Kingdom
-
GlaxoSmithKlineIqvia Pty LtdCompletedAsthmaUnited States, France, Germany, Poland, Spain, Italy, United Kingdom, China, Canada, Czechia, Russian Federation, Ireland
-
Boehringer IngelheimCompletedAsthmaUnited States, Canada, France, Germany
-
Regeneron PharmaceuticalsSanofiCompletedStudy to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)Atopic Dermatitis (AD)United States, Canada
-
AstraZenecaCompletedAsthmaUnited States, Canada, Germany, Poland, Hungary, Slovakia
-
Hoffmann-La RocheCompletedAsthmaSpain, Belgium, United States, Canada, United Kingdom, France, Netherlands, Australia, New Zealand, Puerto Rico, Poland, Mexico, Slovakia, Slovenia, Czechia, Denmark
-
Galaxia EmpíricaSociedad Española de Neumología y Cirugía TorácicaRecruiting
-
Upstream Bio Inc.RecruitingSevere AsthmaUnited States, Canada
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Spain, United States, Turkey, Canada, Hungary, Slovakia, Italy, Argentina, Czech Republic, France, Peru
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Belgium, Poland, Latvia, Argentina, Czechia, Russian Federation, Japan, Hungary, Bulgaria, Philippines, Slovakia, Canada
-
AstraZenecaCompletedAsthmaGermany, Hungary, India, Italy, Canada, France
-
SkyePharma AGCompleted
-
Ception TherapeuticsCephalonCompletedAsthmaUnited States, Canada
-
Teva Branded Pharmaceutical Products R&D, Inc.Recruiting
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaTaiwan, Turkey, Belgium, Spain, Germany, India, Argentina, Canada, Russian Federation, Hungary
-
Hoffmann-La RocheCompletedAtopic DermatitisUnited States, Canada
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, Russian Federation, Mexico, Australia, Ukraine
-
MedImmune LLCMedImmune LtdCompletedAsthmaUnited States, Brazil, Bulgaria, Mexico, Peru, Poland, Russian Federation, Argentina, Canada, Colombia
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital...Enrolling by invitationInfant, Premature, Diseases | Asthma | Allergy | Infant Conditions | Asthma in Children | Infant ALLCanada
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Italy, Japan, Vietnam, Spain, Germany, Malaysia
-
AmgenCompletedAsthmaUnited States, Korea, Republic of, Russian Federation, Poland, Finland, Austria, Belgium, Canada, Netherlands, Hungary
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Mexico, United States, Hungary, Italy, Argentina, Australia, Brazil, Canada, Chile, Colombia, Lithuania, Poland, Romania, Russian Federation, South Africa, Turkey, Ukraine
-
Hoffmann-La RocheCompletedAsthmaKorea, Republic of, United States, Belgium, Czechia, Germany, Peru, Bulgaria, Russian Federation, Argentina, Ukraine, Canada, Poland, South Africa, New Zealand, Romania
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaBelgium, Israel, United States, Mexico, Argentina, Brazil, Canada, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
-
AstraZenecaCompleted
-
Genentech, Inc.CompletedUrticariaUnited States, Germany, Canada
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Poland, Korea, Republic of, Spain, France, China, United Kingdom, Canada, Netherlands, Argentina, Mexico, Brazil, Hungary, Japan, Philippines, South Africa, Colombia
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, Japan, France, Netherlands, Canada, Italy, Slovakia, United States, Hungary
-
GlaxoSmithKlineRecruitingAsthmaUnited States, Canada, Argentina, Australia, Japan, Korea, Republic of, Taiwan
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Canada, Philippines, Brazil
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Germany, Poland, Romania, Russian Federation, Ukraine, Canada, Chile, France, Korea, Republic of, United Kingdom
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Slovakia, Bulgaria, Canada, Poland, Korea, Republic of, Netherlands, Japan
-
AstraZenecaCompletedAsthmaCanada, Vietnam, Russian Federation, Korea, Republic of, Brazil, Peru, China, Ukraine, South Africa, Australia, Bulgaria, Hungary, Poland, Philippines, Romania, Mexico, Chile, United Kingdom
-
Bond Avillion 2 Development LPCompletedAsthmaUnited States, Canada, Germany, Spain, South Africa, United Kingdom, Slovakia, Argentina, Ukraine, Serbia, Czechia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Canada, Germany, Sweden, Russian Federation, United Kingdom
-
Hoffmann-La RocheCompletedAsthmaUnited States, United Kingdom, Belgium, Canada, France, Germany, Bulgaria, Denmark, Hungary, Italy, Latvia, Netherlands, Portugal, Russian Federation, Spain
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Poland, Russian Federation, Belgium, Canada, Chile, France, Germany, Korea, Republic of, Netherlands, Peru, Philippines, South Africa, Sweden, Thailand
-
Boehringer IngelheimCompletedAsthmaUnited States, Australia, Canada, Colombia, Korea, Republic of, Mexico, New Zealand, Peru, Philippines, Taiwan